We have found that low dose naltrexone (LDN) can substantially reduce pain associated with
fibromyalgia syndrome. We believe LDN may work via novel anti-inflammatory channels. The
purpose of this study is to determine if LDN lowers inflammatory markers in individuals with
fibromyalgia.
Phase:
N/A
Details
Lead Sponsor:
Stanford University University of Alabama at Birmingham